Literature DB >> 28339886

Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention.

Todd M Rosenthal1, Daniel Masvidal1, Freddy M Abi Samra1, Michael L Bernard1, Sammy Khatib1, Glenn M Polin1, Paul A Rogers1, Joel Q Xue2, Daniel P Morin1,3.   

Abstract

Aims: Several published investigations demonstrated that a longer T-peak to T-end interval (Tpe) implies increased risk for ventricular tachyarrhythmia (VT/VF) and mortality. Tpe has been measured using diverse methods. We aimed to determine the optimal Tpe measurement method for screening purposes. Methods and results: We evaluated 305 patients with LVEF ≤ 35% and an implantable cardioverter-defibrillator implanted for primary prevention. Tpe was measured using seven different methods described in the literature, including six manual methods and the automated algorithm '12SL', and was corrected for heart rate. Endpoints were VT/VF and death. To account for differences in the magnitude of Tpe measurements, results are expressed in standard deviation (SD) increments. We evaluated the clinical utility of each measurement method based on predictive ability, fraction of immeasurable tracings, and intra- and interobserver correlation. >Over 31 ± 23 months, 82 (27%) patients had VT/VF, and over 49 ± 21 months, 91 (30%) died. Several rate-corrected Tpe measurement methods predicted VT/VF (HR per SD 1.20-1.34; all P < 0.05), and nearly all methods (both corrected and uncorrected) predicted death (HR per SD 1.19-1.35; all P < 0.05). Optimal predictive ability, readability, and correlation were found in the automated 12SL method and the manual tangent method in lead V2.
Conclusion: For the prediction of VT/VF, the utility of Tpe depends upon the measurement method, but for the prediction of mortality, most published Tpe measurement methods are similarly predictive. Heart rate correction improves predictive ability. The automated 12SL method performs as well as any manual measurement, and among manual methods, lead V2 is most useful.

Entities:  

Mesh:

Year:  2018        PMID: 28339886     DOI: 10.1093/europace/euw430

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy.

Authors:  Naoko Tashiro; Jun Muneuchi; Hiroki Ezaki; Masaru Kobayashi; Hiromu Yamada; Yuichiro Sugitani; Mamie Watanabe
Journal:  Pediatr Cardiol       Date:  2022-03-13       Impact factor: 1.838

2.  No Association Between T-peak to T-end Interval on the Resting ECG and Long-Term Incidence of Ventricular Arrhythmias Triggering ICD Interventions.

Authors:  Peter Michalek; Sasha Benjamin Hatahet; Martin Svetlosak; Peter Margitfalvi; Iveta Waczulikova; Sebastian Trnovec; Allan Böhm; Ondrej Benacka; Robert Hatala
Journal:  Front Physiol       Date:  2020-08-31       Impact factor: 4.566

3.  Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval.

Authors:  Mohammad Iqbal; Viky Victory; Astri Astuti; Mega Febrianora; Giky Karwiky; Chaerul Achmad; Mohammad Rizki Akbar
Journal:  Cardiol Res       Date:  2020-08-01

4.  Editorial: Risk Stratification Strategies for Cardiac Rhythm Abnormalities.

Authors:  Gary Tse; Nan Zhang; Wenhua Song; Konstantinos P Letsas; Tachapong Ngarmukos; Kamalan Jeevaratnam; Tong Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-27

5.  Demographic and Methodological Heterogeneity in Electrocardiogram Signals From Guinea Pigs.

Authors:  Kazi T Haq; Blake L Cooper; Fiona Berk; Anysja Roberts; Luther M Swift; Nikki Gillum Posnack
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

6.  The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course.

Authors:  Nijad Bakhshaliyev; Ramazan Özdemir
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-06       Impact factor: 1.468

7.  Myocardial electrophysiological and mechanical changes caused by moderate hypothermia-A clinical study.

Authors:  Kristin Wisløff-Aase; Helge Skulstad; Kristina Haugaa; Per Snorre Lingaas; Jan Otto Beitnes; Per Steinar Halvorsen; Andreas Espinoza
Journal:  Physiol Rep       Date:  2022-04

8.  The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.

Authors:  José Alberto Navarro-García; Rafael Salguero-Bodes; Laura González-Lafuente; Laura Martín-Nunes; Elena Rodríguez-Sánchez; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Jorge Solís; Fernando Arribas; Héctor Bueno; Makoto Kuro-O; María Fernández-Velasco; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.